Compare CNTN & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTN | WALD |
|---|---|---|
| Founded | 2017 | 1988 |
| Country | United States | United Kingdom |
| Employees | 3 | 332 |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.2M | 195.9M |
| IPO Year | 2022 | N/A |
| Metric | CNTN | WALD |
|---|---|---|
| Price | $3.41 | $1.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $3.70 |
| AVG Volume (30 Days) | ★ 533.9K | 56.9K |
| Earning Date | 02-23-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $14.53 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.46 | $1.41 |
| 52 Week High | $5.27 | $3.34 |
| Indicator | CNTN | WALD |
|---|---|---|
| Relative Strength Index (RSI) | 24.60 | 31.94 |
| Support Level | N/A | N/A |
| Resistance Level | $4.78 | $2.06 |
| Average True Range (ATR) | 0.34 | 0.12 |
| MACD | -0.13 | -0.02 |
| Stochastic Oscillator | 10.63 | 12.20 |
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.